LD-2 disclosure · 4th Quarter - Report
ONYX PHARMACEUTICALS
Expenses$90Kself-filed spend
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Onyx Pharmaceuticals develops and commercialize innovative cancer therapies.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Cancer health disparities, Fiscal Cliff discussions, and Sequestration
LobbyistsDEANNA DARLINGTON · mr JOHN EVERETT CROSLAND iii
Covered position (mr JOHN EVERETT CROSLAND iii): Press Staff Asst., Sen. Evan Bayh
TargetedSENATE · HOUSE OF REPRESENTATIVES